Health
Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine – News-Medical.net
A study developed a protein-based subunit vaccine, PHH-1V, that consisted of a recombinant RBD fusion heterodimer of the alpha)…
The emergence of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led the scientific community and pharmaceutical industry to focus on the development of vaccines to combat the health…
Continue Reading
-
General21 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News23 hours agoSunshine Coast women celebrated at 26th annual business awards
-
Noosa News15 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News24 hours agoNew FLC President has regional lens – Proctor